MPS 7
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Mucopolysaccharidosis VII Disease Monitoring Program (NCT03604835) | Ultragenyx Pharmaceutical Inc | 2018-01-29 |
| A Phase 3 Study of UX003 Recombinant Human Betaglucuronidase (rhGUS) Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis Type 7 (MPS 7) (NCT02230566) | Ultragenyx Pharmaceutical Inc | 2014-12-01 |
Track MPS 7 automatically
Every clearance here is in the API, with alerts when new ones post.